USPTO serial 79442020
CORE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- PERITZ, SARAH L
- Law office
- TMO LAW OFFICE 129
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with CORE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations for use in industry and science; chemical products for use in industry and science; stem cells and cell cultures for scientific and laboratory research; stem cells for scientific and research purposes; cell culture reagents for scientific and research use; reagents and culture media for cell growth, genetic modification, and tissue engineering; chemical, biochemical, and biological substances for use in the manufacture of pharmaceuticals and medical therapies; biotechnological preparations for scientific research purposes; enzymes, proteins and nucleic acids for use in biotechnology and genetic engineering; diagnostic preparations, namely clinical diagnostics, other than for medical or veterinary use; diagnostic preparations for scientific use | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations; chemical and biological reagents for medical and veterinary use; human and animal cells and parts thereof for medical and veterinary purposes; stem cells; stem cells for medical purposes; biological preparations for medical purposes; biotechnological preparations for medical use; pharmaceutical and therapeutic preparations for use in regenerative medicine, cell therapy and gene therapy; stem cells and cell-based pharmaceutical products for medical and clinical use; gene therapy products; gene therapy products for the treatment of genetic disorders, neurological conditions, immune system disorders and cancer; biopharmaceuticals for use in cellular and genetic treatments; chemical preparations for medical purposes; enzymes and enzyme preparations for medical purposes; implantable medicines, living tissues and bioengineered tissues for medical and surgical applications; gene therapy and prophylaxis products; pharmaceutical substances and preparations for gene therapy and prophylaxis; vaccines; chemical products for use in medical science in the field of gene therapy and prophylaxis | ACTIVE | — |
| 040 | Chemical, biological and mechanical processing or transformation of cells; production of cell lines; cryopreservation services; custom manufacturing of biological and pharmaceutical products, including gene and cell therapy preparations; processing of biological materials, including stem cells, gene therapy vectors, and tissue samples; custom manufacture of pharmaceuticals; custom manufacture of products relating to biotechnology; custom manufacturing services for third parties in the field of biotechnology, pharmaceuticals and regenerative medicine; bioprocessing services for the preparation and formulation of cell and gene therapy products; information, advisory and consultancy services relating to all of the aforesaid services | ACTIVE | — |
| 041 | Educational and training services; educational services, including conducting seminars, workshops and training sessions in the fields of biotechnology, regenerative medicine, cell therapy and gene therapy; electronic publication of research, articles and instructional materials; electronic publication of research, articles and instructional materials in the fields of biotechnology, medicine, and life sciences; information, advisory and consultancy services relating to all of the aforesaid services | ACTIVE | — |
| 042 | Scientific research and development services; genetic engineering services; genetic engineering laboratories and biochemistry laboratories services; scientific and technological services and research; industrial analysis services; provision of information relating to scientific research; provision of scientific information; research and scientific analysis relating to drug discovery and development for others; scientific advisory services; scientific consultancy; scientific research and development; scientific research in the field of biotechnology and pharmaceuticals; management of scientific research projects; issuing of scientific information; advisory services relating to scientific and clinical research; biological research, clinical research and medical research; clinical research; conducting clinical trials; services relating to the creation and alteration of chemical and biological reagents; quality control and assurance services; biotechnological and pharmaceutical research services; development and testing of cell and gene therapy products; gene therapy research services; genetic engineering services; genetic engineering and stem cell research; contract research services for third parties in the biotechnology and pharmaceutical industries; laboratory services; biological laboratory services; laboratory services for analysis, testing, and validation of biological products; biotechnology services; biochemical engineering, research and analysis services; biological research and analysis services; quality control and validation services; information, advisory and consultancy services relating to all of the aforesaid services | ACTIVE | — |
| 044 | Medical services relating to regenerative medicine, cell therapy, and gene therapy; services for medical analysis; medical services relating to the removal, treatment and processing of human cells; stem cell therapy services; stem cell bank and storage services; stem cell banking and preservation services for medical purposes; medical consultancy and advisory services in the field of biopharmaceuticals, genetic therapy, and regenerative medicine; medical diagnostic services; issuing of medical reports; consultancy, advice and information in the field of healthcare, pharmaceuticals and advanced therapy medicinal products; consultancy, advice and information in the field of healthcare, pharmaceuticals and advanced therapy medicinal products information, advisory and consultancy services relating to all of the aforesaid services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Roslin Cell Therapies Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CORE
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 23, 2026 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 23, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 30, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 11, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 10, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 29, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 28, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 26, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 25, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 25, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 22, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |